Snoasis Medical, LLC
Developing regenerative solutions for dental surgery, enhancing healing with state-of-the-art allografts, designed for ease of use and long-term storage.
Developing regenerative solutions for dental surgery, enhancing healing with state-of-the-art allografts, designed for ease of use and long-term storage.
Snoasis Medical, LLC is a US-based startup that specializes in developing regenerative tissue and medical device solutions for dental surgery. Their flagship product, BioXclude de-epithelialized amnion-chorion allograft, is processed using Purion to supply a range of extracellular matrix proteins, growth factors, and cytokines, serving as a barrier membrane to enhance healing. These user-friendly allografts can be stored at room temperature for up to five years, adding to their convenience. The company holds global distribution rights to current and future MiMedx placental tissue products and has an exclusive license for relevant intellectual property in dental and oral maxillofacial applications. Snoasis Medical aims to deliver innovative and cost-effective regenerative products, benefiting both clinicians and patients. The company was founded in 2007 and is headquartered in Golden, Colorado, United States. Their last investment was a $250.00K grant investment through the Advanced Industries Accelerator (AIA) Program on 18 November 2021. Snoasis Medical's focus on regenerative solutions for dental surgery, along with their recent investment and partnerships, positions them as a promising player in the health care and medical devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $250.00K | 1 | Advanced Industries Accelerator (AIA) Program | 18 Nov 2021 |
No recent news or press coverage available for Snoasis Medical, LLC.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
